Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
90 participants
INTERVENTIONAL
2015-10-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome
NCT02857465
Dexamethasone and Induction of Delivery
NCT03658590
Effect of Dexamethasone on Labour Induction in Term Pregnancies
NCT07109258
Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour
NCT02508402
Role Of Dexamethasone In Induction Of Labor
NCT03603418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group L
Epidural levobupivacaine 0.125% (Chirocaine) in normal saline in a total volume of 10 ml will be administered epidurally in active stage of labor
Levobupivacaine
Levobupivacaine will be given epidurally and the duration of analgesia will be calculated
group LD4
Epidural levobupivacaine 0.125%(Chirocaine) in normal saline combined with dexamethasone 4 mg in a total volume 10 ml
Dexamethasone and levobupivacaine
dexamethasone 4 mg epidurally with levobupivacaine and duration of analgesia is measured
group LD8
Epidural levobupivacaine 0.125%(Chirocaine) in normal saline combined with dexamethasone 8 mg in a total volume 10 ml
Levobupivacaine and Dexamethasone
dexamethasone 8 mg epidurally with levobupivacaine and duration of analgesia is measured
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levobupivacaine
Levobupivacaine will be given epidurally and the duration of analgesia will be calculated
Dexamethasone and levobupivacaine
dexamethasone 4 mg epidurally with levobupivacaine and duration of analgesia is measured
Levobupivacaine and Dexamethasone
dexamethasone 8 mg epidurally with levobupivacaine and duration of analgesia is measured
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal vaginal delivery In early active phase of labor
* singleton cephalic presentation at term
Exclusion Criteria
* morbid obesity
* diagnosed fetal abnormalities
* contra-indications to regional anesthesia
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmed elsakka
m.d. anasthesia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed i elsakka, m,d,
Role: PRINCIPAL_INVESTIGATOR
Cairo University
amira r hassan, m,d.
Role: STUDY_CHAIR
Cairo University
nadia y helmy, m.d.
Role: STUDY_DIRECTOR
Cairo University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
wahdan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.